The field of mycology has evolved from an underappreciated area of botany to a vital scientific discipline. This paper reviews current research, limitations, and future directions in mycology, focusing on emerging diseases, drug discovery, phylogenomics, functional genomics, and the role of fungi in biocircular economies. Fungi are increasingly important in medical mycology, with emerging diseases linked to immunosuppression and environmental factors. Current trends in drug discovery highlight the potential of fungi for novel compounds, while phylogenomics and functional genomics are advancing our understanding of fungal biology and ecology. The importance of Arbuscular Mycorrhizal Fungi and fungal databases is also discussed. The paper addresses the impact of metrics on mycology research, noting the shift from ecological to molecular studies and the increasing focus on biodiversity, taxonomy, and phylogeny. The golden era of mycology is highlighted, with increased funding and research opportunities in Asia and South America. Emerging diseases are a major concern, with fungal infections becoming more prevalent due to immunosuppression and environmental changes. Antifungal resistance is a growing problem, requiring new therapeutic approaches. Reliable diagnostics are essential for effective disease management, and advances in AI and multi-microbial tools are promising. In drug discovery, fungi remain a key source of natural products, with recent advances in genome mining and synthetic biology enabling the identification of novel compounds. Phylogenomics is transforming fungal classification, but limitations in genomic sampling and computational resources hinder its widespread application. Fungal plant pathogens have a long evolutionary history, with genomics providing insights into their adaptation and virulence. Overall, the field of mycology is rapidly evolving, with significant potential for future research and applications in medicine, industry, and ecology.The field of mycology has evolved from an underappreciated area of botany to a vital scientific discipline. This paper reviews current research, limitations, and future directions in mycology, focusing on emerging diseases, drug discovery, phylogenomics, functional genomics, and the role of fungi in biocircular economies. Fungi are increasingly important in medical mycology, with emerging diseases linked to immunosuppression and environmental factors. Current trends in drug discovery highlight the potential of fungi for novel compounds, while phylogenomics and functional genomics are advancing our understanding of fungal biology and ecology. The importance of Arbuscular Mycorrhizal Fungi and fungal databases is also discussed. The paper addresses the impact of metrics on mycology research, noting the shift from ecological to molecular studies and the increasing focus on biodiversity, taxonomy, and phylogeny. The golden era of mycology is highlighted, with increased funding and research opportunities in Asia and South America. Emerging diseases are a major concern, with fungal infections becoming more prevalent due to immunosuppression and environmental changes. Antifungal resistance is a growing problem, requiring new therapeutic approaches. Reliable diagnostics are essential for effective disease management, and advances in AI and multi-microbial tools are promising. In drug discovery, fungi remain a key source of natural products, with recent advances in genome mining and synthetic biology enabling the identification of novel compounds. Phylogenomics is transforming fungal classification, but limitations in genomic sampling and computational resources hinder its widespread application. Fungal plant pathogens have a long evolutionary history, with genomics providing insights into their adaptation and virulence. Overall, the field of mycology is rapidly evolving, with significant potential for future research and applications in medicine, industry, and ecology.